Back to All Events

BioVenturing from Lab to Industry

  • Hero House Glendale 326 Mira Loma Avenue Glendale, CA, 91204 United States (map)

Join us to explore technology transfer from lab to market and meet inventors and innovators who have moved scientific research in Biotech and Healthcare into business ventures. Throughout the whole day, we will host scientist entrepreneurs, investors, biopharma executives, and others in the space from SoCal, Bay Area, and East Coast who are pioneering the future of healthcare.

Who should attend: Students and faculty members interested in the why and how of commercializing their research; biotech and healthcare executives exploring the technology edge in the space and ways to get involved in the startup world; biotech and healthcare entrepreneurs and investors; wider biotech community representatives; anyone curious about healthcare innovations.

AGENDA:

1:30 - 2:30 PM | WELCOME REFRESHMENTS AND NETWORKING

2:30 - 3:00 PM | RISK, EQUITY, TRACTION: INVESTORS’ VIEW ON HEALTHCARE / LIFE SCIENCES

Speaker and Moderator: Jack Topdjian, Founder of Healthcare Equity Angels, Venture Partner at SmartGateVC

John Nackel, Partner at Wavemaker 360 Health

Genevieve LeMarchal, Head of Healthcare Ventures Expert Dojo, Managing Partner at Suncoast Ventures

Michael Dal Bello, Founder of Curewell Capital

Mikayel Nazloyan, Partner at PwC

Ashot Arzumanyan, Partner at SmartGateVC

3:00 - 3:30 PM | UNIVERSITY AS THE BACKBONE FOR TECHNOLOGY TRANSFER FROM LAB TO INDUSTRY

Moderator: Siranush Babakhanova, Stanford Biophysics PhD Candidate

Tariq Arif, Business Development Officer at UCLA Technology Development Group

Camilo Ansarah-Sobrinho, Associate Director, Business Development and Industry Relations at USC MESH Academy

Stacyann Russell, Director of NSF I-Corps Hub West Region

3:30 - 4:00 PM | BIOVENTURING: FROM SCIENTIST TO ENTREPRENEUR

Moderator: Meghedi Babakhanian, Senior Research Engineer at Stanford University School of Medicine, CEO at EPIENDOAF

Gerald E. Loeb, Professor, Director Of The Medical Device Development Facility at USC

Garegin Papoian, Monroe Martin Professor at the University of Maryland, Founder and CEO of Biosim

Ruben Abagyan, Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, Founder of Molsoft

Lusine Abgaryan, Co-Founder & CEO at GrittGene Therapeutics

4:00 - 4:30 PM | INNOVATING IN HEALTHCARE: CHALLENGES AND OPPORTUNITIES

Leo Petrossian, CEO at Nile AI

Harry Glorikian, General Partner at Scientia Ventures

Llewellyn Cox, CEO at Lab Launch, General Partner at MarsBio

4:30 - 5:00 PM | WHEN AND HOW TO TALK TO PHARMA

Moderator: Rafi Vartanian, Director of Commercial Strategy & Effectiveness at Customerinsights.ai

Elizabeth Wu, Director, Early Innovation Partnering at Johnson & Johnson

Sev G. Sislian, Executive Director, Global Head of Sourcing, Operations and R&D at Amgen

Stephanie Hsieh, Executive Director of Los Angeles, Biocom California

5:00 - 6:00 PM | NETWORKING


In compliance with the Americans with Disabilities Act (ADA) of 1990, assistive listening devices are available upon request. Requests must be submitted 72 hours in advance. Please contact 818-548-2005 to submit a request.